Evelo Biosciences (EVLO) Financial Statements

211 Followers

Evelo Biosciences Financial Overview

Evelo Biosciences's market cap is currently $19.00. The company's EPS TTM is $; its P/E ratio is ―; Evelo Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -108.47M	$ -115.40M	$ -91.89M	$ -86.36M	$ -58.10M
EBITDA	$ -106.34M	$ -115.40M	$ -89.86M	$ -84.42M	$ -58.10M
Net Income	$ -114.53M	$ -122.18M	$ -93.67M	$ -85.66M	$ -53.85M
Balance Sheet
Cash & Short-Term Investments	$ 47.94M	$ 68.44M	$ 68.86M	$ 77.83M	$ 147.92M
Total Assets	$ 64.44M	$ 87.87M	$ 90.64M	$ 90.92M	$ 159.87M
Total Debt	$ 51.14M	$ 56.29M	$ 40.04M	$ 19.63M	$ 12.30M
Net Debt	$ 3.20M	$ -12.15M	$ -28.82M	$ -58.20M	$ -135.61M
Total Liabilities	$ 69.43M	$ 79.20M	$ 60.15M	$ 30.72M	$ 22.92M
Stockholders' Equity	$ -4.99M	$ 8.67M	$ 30.48M	$ 60.20M	$ 136.95M
Cash Flow
Free Cash Flow	$ -101.86M	$ -98.24M	$ -74.38M	$ -75.01M	$ -52.74M
Operating Cash Flow	$ -101.23M	$ -96.72M	$ -73.06M	$ -71.98M	$ -47.28M
Investing Cash Flow	$ -622.00K	$ -1.48M	$ -1.31M	$ 51.97M	$ -60.13M
Financing Cash Flow	$ 81.66M	$ 97.54M	$ 65.47M	$ 4.99M	$ 162.01M

Currency in USD

Evelo Biosciences Earnings and Revenue History

Income Statement >

Evelo Biosciences Debt to Assets

Balance Sheet >

Evelo Biosciences Cash Flow

Cash Flow >

Evelo Biosciences Forecast EPS vs Actual EPS

Earnings >